With regard to the healthcare pathways considered, for prostate cancer, PRS-based screening strategies were based either on PR alone31 or on a combination of PRS and other factors, especially age and/or prostate-specific antigen (PSA) levels.27 This evidence concerns the gene KLK3 and prostate cancer.